EUVIMEDEUVIMED entdecken
Fallbericht

Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes

Ke Wang, Fei Wang, Ye Jin, Su-Wan Liu, Yuan Feng, Yong-Hui Ji, Jing-Dong Zhou, Jun Qian

Transplant Immunology · 2026

DOI: 10.1016/j.trim.2026.102434 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplant Immunology, 2026. Verfasst von Ke Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhenjiang Clinical Medical College of Nanjing Medical University, The No. 1 People's Hospital of Zhenjiang, Zhenjiang 212002, Jiangsu, PR China; Inst…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Cord Blood Stem Cell Transplantation, HLA Antigens. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transplantation involving human leukocyte antigen (HLA) haplotype-homozygous individual is a rare circumstance, and for the unidirectional HLA mismatches in some cases, its transplant prognosis exhibits certain characteristics. This report details a case of an adverse-risk acute myeloid leukemia (AML) patient with near-homozygous HLA haplotypes who underwent double units unrelated umbilical cord blood transplant (dUCBT) twice. Molecular relapse was detected 1 year and 2 years after the first transplantation, and complete remission (CR) was regained by drug therapy (venetoclax and azacitidine) on both occasions. A second transplantation was performed after hematologic relapse occurred 3 years later. The patient remained clinically stable for one year after CR again, without graft-versus-host disease symptoms. This case suggests that second UCBT for relapsed adverse-risk AML with near-homozygous HLA haplotypes is feasible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationHLA AntigensHumansHaplotypesRecurrenceMaleHomozygoteAdult

Stichwörter der Autor:innen

Acute myeloid leukemiaDouble units unrelated umbilical cord blood transplantationNear-homozygous HLA haplotypesSecond transplantation

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Zhenjiang Clinical Medical College of Nanjing Medical University, The No. 1 People's Hospital of Zhenjiang, Zhenjiang 212002, Jiangsu, PR China; Institute of Hematology, Jiangsu University, Zhenjiang 212002, Jiangsu, PR…
  • Zhenjiang Clinical Medical College of Nanjing Medical University, The No. 1 People's Hospital of Zhenjiang, Zhenjiang 212002, Jiangsu, PR China; Laboratory Center, The No. 1 People's Hospital of Zhenjiang, Zhenjiang 212…

Zitieren

APA

Wang, K., Wang, F., Jin, Y., Liu, S. W., Feng, Y., Ji, Y. H., Zhou, J. D., & Qian, J. (2026). Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102434

Vancouver

Wang K, Wang F, Jin Y, Liu SW, Feng Y, Ji YH, et al. Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102434

BibTeX
@article{Wang2026,
  author = {Wang, Ke and Wang, Fei and Jin, Ye and Liu, Su-Wan and Feng, Yuan and Ji, Yong-Hui and Zhou, Jing-Dong and Qian, Jun},
  title = {Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes},
  journal = {Transplant Immunology},
  year = {2026},
  doi = {10.1016/j.trim.2026.102434}
}
Kostenlos starten →